Cutler Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100
Closed -$1K 4322
2023
Q2
$1K Sell
100
-300
-75% -$23K ﹤0.01% 3421
2023
Q1
$12K Buy
+400
New +$27.7K ﹤0.01% 2232
2021
Q4
Sell
-1,800
Closed -$3K 6076
2021
Q3
$3K Hold
1,800
﹤0.01% 4866
2021
Q2
$7K Sell
1,800
-13,700
-88% -$380K ﹤0.01% 4224
2021
Q1
$55K Buy
+15,500
New +$477K ﹤0.01% 2299

Other funds holding TMDX

Cutler Group's TMDX Position: Q4 2023 in Review

Cutler Group sold out of Transmedics (TMDX) in Q4 2023, closing a stake of 700 shares — an estimated $38K sold.

Cutler Group first reported a position in TMDX in Q2 2021 and held it in 7 quarters. The position peaked at $218K in Q3 2021. 248 funds tracked by Wall St. Rank hold TMDX as of Q4 2023.

  • Cutler Group reported no remaining Transmedics position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 700 Transmedics shares in Q4 2023, an estimated $38K.
  • Cutler Group first reported a position in Transmedics in Q2 2021 and held it in 7 quarters.
  • Cutler Group's Transmedics position peaked at $218K in Q3 2021.
  • 248 funds tracked by Wall St. Rank held Transmedics as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.